These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16552809)

  • 1. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial.
    Romanelli RG; La Villa G; Barletta G; Vizzutti F; Lanini F; Arena U; Boddi V; Tarquini R; Pantaleo P; Gentilini P; Laffi G
    World J Gastroenterol; 2006 Mar; 12(9):1403-7. PubMed ID: 16552809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
    Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
    J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
    Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
    J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
    García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
    Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
    Gentilini P; Casini-Raggi V; Di Fiore G; Romanelli RG; Buzzelli G; Pinzani M; La Villa G; Laffi G
    J Hepatol; 1999 Apr; 30(4):639-45. PubMed ID: 10207805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
    Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
    Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
    Sersté T; Melot C; Francoz C; Durand F; Rautou PE; Valla D; Moreau R; Lebrec D
    Hepatology; 2010 Sep; 52(3):1017-22. PubMed ID: 20583214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour.
    Laffi G; Gentilini P; Romanelli RG; La Villa G
    Dig Liver Dis; 2003 Sep; 35(9):660-3. PubMed ID: 14563190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for chronic albumin infusion.
    Perkins JD
    Liver Transpl; 2006 Feb; 12(2):320-1. PubMed ID: 16447190
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
    Caraceni P; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Boccia S; Svegliati-Baroni G; Fagiuoli S; Romanelli RG; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Tortora A; De Marco R; Angelico M; Cacciola I; Elia G; Federico A; Massironi S; Guarisco R; Galioto A; Ballardini G; Rendina M; Nardelli S; Piano S; Elia C; Prestianni L; Cappa FM; Cesarini L; Simone L; Pasquale C; Cavallin M; Andrealli A; Fidone F; Ruggeri M; Roncadori A; Baldassarre M; Tufoni M; Zaccherini G; Bernardi M;
    Lancet; 2018 Jun; 391(10138):2417-2429. PubMed ID: 29861076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites.
    Sinha R; Lockman KA; Mallawaarachchi N; Robertson M; Plevris JN; Hayes PC
    J Hepatol; 2017 Jul; 67(1):40-46. PubMed ID: 28213164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
    Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
    Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic schemes for refractory ascites of advanced schistosomiasis: a clinical control study].
    He HR; Li M; Wei DP; Zhu JJ; Yang JB; Feng XH; Din W; Zhou RB; Lu GZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Oct; 24(5):570-2. PubMed ID: 23373268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial.
    Adhami JE; Basho J
    Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.
    Pompili E; Baldassarre M; Iannone G; Tedesco G; Nardelli S; Piano S; Alessandria C; Neri S; Foschi FG; Levantesi F; Caraceni P; Bernardi M; Zaccherini G;
    Liver Int; 2024 Sep; 44(9):2108-2113. PubMed ID: 38934515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
    Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
    Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.